Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Non-Clinicians / Medical Office Support Staff / Industry Participants

Non-clinicians--including, but not limited to, office managers, billing specialists, receptionists, and administrative staff--may attend PAINWeekEnd on a space-available basis when accompanied by a clinician and will be put on a wait list. These non-clinicians must still pre-register. Participation in industry sponsored meal programs, however, is strictly limited to practicing licensed healthcare providers. Please make necessary arrangements for meals for office support staff. In order to maintain the professional nature of the conference, guests, spouses, friends, and/or family members who are not currently employed in the medical field may not attend PAINWeekEnd.


Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

Discounted self-parking is $4.

Hilton Sacramento Arden West
2200 Harvard Street
Sacramento, CA


To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!


Click on the day of the conference to see course descriptions, UAN numbers, and AANP pharmacology credits.

Saturday, October 20, 2018

Schedule (subject to change)

7:00a - 7:30a - Registration and Exhibits
Coffee will be served. 

7:30a - 8:30p - The Psychology Toolbox: Evidence Based Treatments for Pain Management

UAN 0530-0000-18-332-L01-P

AANP Rx Hours 0.0

Course Description

The opioid epidemic has caused many patients, clinicians, and payers to seek nonpharmacologic options to assist with managing pain. Psychology has a well-established role in the treatment of pain conditions but familiarity with the range of pain related interventions varies widely among clinicians. The Psychology Toolbox seeks to fill the knowledge gap by briefly explaining the role of psychology in pain treatment and reviewing a range of evidence based interventions to assist this burgeoning clinical population. Although cognitive behavioral therapy based interventions are the most frequently studied and applied paradigms, a number of other treatments also have demonstrated efficacy in pain care, but are lesser known. Thus, cognitive behavioral therapy for pain will be discussed, followed by an overview of several other pain treatment modalities: biofeedback training, mindfulness based stress reduction, and acceptance and commitment therapy. At the conclusion of the session, participants should possess a greater awareness of the vast array of evidence based treatments that can be used to help this group of individuals.

Ravi Prasad, PhD

8:30a - 9:30a - Product, Disease Awareness, Medical Information Program*
Breakfast will be served.
Sponsored by Teva, Andrew Michael Blumenfeld, MD, FAHS

9:30a - 9:40a - Break & Exhibits

9:40a - 10:40a - Recent Advances in Opioid Abuse Deterrent Formulations

UAN 0530-0000-18-201-L01-P

AANP Rx Hours 0.0

Course Description

In 2017 the United States declared the opioid crisis as a public health emergency. The growing awareness of opioid related harms began much earlier and active efforts have been ongoing for over the last 10 years. Although the healthcare system has little impact on the illegal manufacturing, distribution, and abuse of illicit opioids, the healthcare system can positivity take steps to reduce the abuse of legitimate medical opioids. Many misconceptions exist regarding prescription opioid abuse and positive solutions will occur when specific problems are addressed, such as drug diversion and the way people abuse opioids. This course will review abuse mitigation strategies with particular focus on the technological enhancement to reduce abuse, especially the diversion, of prescription opioids, their process for obtaining FDA approval as abuse-deterrent opioids and a review of current and possible future technologies.

This presentation is supported by an unrestricted educational grant from Daiichi-Sankyo, Inc.

Jeremy A. Adler, MS, PA-C

10:40a - 11:40a - Interdisciplinary Management of Pelvic Pain: Bridging the Gap Between Primary Care and Specialty Referral

UAN 0530-0000-18-333-L01-P

AANP Rx Hours 0.1

Course Description

The prevalence of chronic pelvic pain in women aged 18 to 50 is around 15%. However, only one-third of these women seek medical care. Also, the average time from presentation to a primary care provider and appropriate spe-cialty referral and diagnosis ranges from 3 to 7 years. Not only is it essential for primary care providers to recognize the broad differential diagnoses contributing to pelvic pain, but also to understand appropriate and prompt specialist referral. Furthermore, many of these conditions require ongoing interdisciplinary management for optimal outcomes. In order to enhance care, it is essential for the primary care provider to appreciate the epidemiology, risks factors, and etiology of a spectrum of pelvic pain conditions in addition to relevant treatment options. In order to narrow the gap between current and optimal practice, a case based learning discussion will engage the audience to illustrate aspects of interdisciplinary management relevant to the treatment of pelvic pain.

Jennifer M. Hah, MD, MS

11:40a - 12:00p - Faculty Q&A

12:00p - 12:10p - Break & Exhibits

12:10p - 1:10p - Product, Disease Awareness, Medical Information Program*
Lunch will be served.
Sponsored by AstraZeneca and Daiichi Sankyo Inc.Paul Choi, MD

1:10p - 2:00p - Crisis=Opportunity: Reducing Medication Burden While Managing Chronic Pain

UAN 0530-0000-18-060-L01-P

AANP Rx Hours 0.6

Course Description

Although long regarded as an appropriate standard of care for treating acute and cancer pain, the use of prescription opioids to treat chronic benign pain conditions has been highly controversial. The lack of empirical support in conjunction with the increased prevalence of prescription opioid abuse has subsequently led professional and regulatory boards, as well as the general public, to become more critical of physician prescribing practices. As a result, patients who were once prescribed high doses of opioid medication are now being told that they need to reduce or eliminate their reliance on this form of treatment. How can individuals successfully eliminate use of a substance that they have relied on for an extended period of time? Current literature related to the use of opioids will be reviewed along with the medical challenges associated with weaning individuals off of this class of drug. A psychologist will then speak about the role of interdisciplinary treatment programs in facilitating opioid cessation while concurrently improving patients' functional outcomes. Emphasis will be placed on the critical role that psychological and behavioral interventions play in this process, and the evidence which supports their inclusion.

Ravi Prasad, PhD

2:00p - 2:10p - Break & Exhibits

2:10p - 3:00p - Product, Disease Awareness, Medical Information Program*
Refreshments will be served.
Sponsored by SCILEX, Steven Stanos, DO

3:00p - 3:50p - Case Studies in Aberrant Drug Taking Behavior in Pain Management

UAN 0530-0000-18-404-L01-P

AANP Rx Hours 0.8

Course Description

Many healthcare professionals have experienced aberrant behaviors from patients when prescribing controlled substances. The formulation of a differential diagnosis of the behaviors and having a consistent plan of action is key. This presentation will draw upon real cases to highlight approaches that may be considered, as well as focus on some of the strengths and weaknesses of patient aberrant behavior monitoring tools. Through case studies and assessment tools, participants in this course will learn to recognize aberrant drug taking behaviors, and various approaches to patient interactions will be demonstrated.

Jeremy A. Adler, MS, PA-C

3:50p - 4:40p - Policies and Practicalities: Focusing on the Patient, Not the Opioid

UAN 0530-0000-18-330-L05-P

AANP Rx Hours 0.5

Course Description

The current opioid epidemic has resulted in numerous professional and society guidelines focused on safe opioid prescribing. In addition, policymakers have focused on state legislation to limit the duration of opioid prescribing for acute pain. As a result of the increased scrutiny, prescribers have shifted their focus to limiting opioid prescribing for patients with chronic noncancer pain. Now, more than ever, evidence based behavioral treatment modalities are essential for fostering pain coping skills and providing support as part of optimal interdisciplinary pain management. This course will begin with a brief review of the opioid epidemic. Current opioid prescribing guidelines will be discussed with a particular emphasis on indications for opioid tapering. Strategies for the medical management of opioid tapering will be presented, along with a detailed discussion of evidence based psychotherapeutic interventions known to result in improvements in physical and emotional functioning while promoting opioid tapering.

Jennifer M. Hah, MD, MS


*Not certified for credit.